Credit: Pexels

FDA approves Zyn nicotine pouches, sparking debate on health and Gen Z trends

Zyn nicotine pouches, a product often praised for their appetite-suppressing effects and unofficially dubbed “Gen Z’s accidental weight loss drug,” have just earned FDA approval. The move allows the popular pouches, available in 10 flavors like coffee, cinnamon, and menthol, to continue being sold in the U.S.

While officially marketed as a safer alternative to cigarettes, young users have been embracing Zyns for far more than their smoking cessation potential. From boosting workouts to staying awake during late-night study sessions, fans credit the pouches with enhancing various aspects of their lives. Some even liken them to a budget-friendly Ozempic for their ability to curb hunger, playfully calling them “O-Zyn-pic.”

What Are Zyn Pouches?

Zyn pouches are small, tobacco-free packets containing nicotine and flavoring. Users insert them between the lip and gum, where they release a steady dose of nicotine over an hour. This steady delivery activates brain receptors that suppress appetite, a side effect many users swear by.

Nicotine’s appetite-suppressing effects trace back to the body’s “fight or flight” response, prioritizing energy conservation over hunger during times of stress. Although this mechanism might explain the weight loss, health experts urge caution, noting nicotine’s addictive potential.

FDA Approval: A Milestone with Mixed Reactions

The FDA’s decision to approve Zyn pouches marks the first authorization for nicotine pouches, the fastest-growing segment in the U.S. tobacco market. Regulators conducted extensive reviews of Philip Morris International’s data, concluding that Zyn is less harmful than traditional cigarettes and some forms of chewing tobacco.

While the approval recognizes Zyn’s potential to help smokers transition away from more harmful tobacco products, it doesn’t mean the pouches are risk-free. Critics worry about the product’s appeal to younger audiences, particularly with flavors like citrus and peppermint.

A Viral Phenomenon

Zyn’s popularity isn’t confined to gas stations or convenience stores—it has gone viral. Social media is teeming with testimonials from young users who rave about their experiences. Some claim Zyn has helped them lose significant weight, with one Instagram influencer joking about shedding “30 pounds in a month.”

Celebrities have also hopped on the Zyn bandwagon. Actor Josh Brolin admitted he’s so hooked he sleeps with them, while NFL quarterback Baker Mayfield faced backlash for using a Zyn on the sidelines. Even Tucker Carlson, a conservative commentator, has publicly praised the product, though some of his remarks were later dismissed as jokes.

Critics Raise Concerns

Despite its growing fan base, Zyn has drawn criticism. Anti-smoking groups argue that flavored nicotine products could follow the same trajectory as e-cigarettes, which faced backlash for sparking a surge in underage use.

“Flavored products have a long history of being used to hook kids, and the FDA should be cautious about repeating past mistakes,” warned Yolonda Richardson from the Campaign for Tobacco-Free Kids.

Philip Morris counters these claims by pointing to data showing fewer than 2% of American high schoolers used nicotine pouches last year.

The Bigger Picture

Zyn represents the tobacco industry’s latest attempt to pivot as traditional cigarette sales continue to decline. Unlike e-cigarettes, which have faced intense regulatory scrutiny, Zyn is marketed as a low-risk alternative, similar to nicotine gums and lozenges.

But whether this product will help more adults quit smoking or create new nicotine dependencies remains to be seen. While the FDA’s decision is a win for Zyn’s parent company, it also opens the door to ongoing debates about nicotine’s role in public health.

Final Thoughts

As Zyn nicotine pouches gain FDA approval, their popularity among Gen Z and young adults underscores a complex mix of benefits and risks. While they may offer a less harmful alternative for smokers, concerns about their appeal to non-smokers and potential long-term effects remain unresolved.

For now, the decision has sparked both celebration and controversy, with Zyn continuing to be a polarizing presence in the wellness and tobacco landscape.